This Article Full Text Full Text (PDF) Submit a related Letter to the Editor Alert me when this article is cited Alert me when eLetters are posted Alert me if a correction is posted Citation Map Services Email this article to a friend Similar articles in this journal Similar articles in PubMed Alert me to new issues of the journal Download to citation manager Request Copyright Permission Citing Articles Citing Articles via HighWire Citing Articles via Google Scholar Google Scholar Articles by Pardini, V. C. Articles by Velho, G. Search for Related Content PubMed PubMed Citation Articles by Pardini, V. C. Articles by Velho, G.

Leptin Levels, ß-Cell Function, and Insulin Sensitivity in Families with Congenital and Acquired Generalized Lipoatropic Diabetes¹

Centro de Pesquisas da Endocrinologia-CEPEN, Santa Casa de Belo Horizonte (V.C.P., I.M.N.V., S.M.V.R., D.G.A., F.B.P., G.M., S.P.), Minas Gerais, Brazil; Endocrinology and Metabolism Center (A.M.R.), Campina Grande, Paraiba, Brazil; and INSERM U342, Hôpital Saint Vincent de Paul (G.V.), Paris, France

Address all correspondence and requests for reprints to: Victor C. Pardini, Rua Aimorés 33, 30140–070 Belo Horizonte, Minas Gerais, Brazil. E-mail: vpardini{at}labhpardini.com.br

Lipoatropic diabetes (LD) designates a group of syndromes characterized by diabetes mellitus with marked insulin resistance and either a localized or generalized absence of adipose tissue. In this study, we evaluated plasma leptin levels in subjects with congenital generalized lipoatropic diabetes (CGLD, n = 11) or acquired generalized lipoatropic diabetes (AGLD, n = 11), and assessed correlations between leptin levels and estimations of insulin secretion and insulin sensitivity using homeostasis model assessment (HOMA). Leptin levels were 0.86 ± 0.32, 1.76 ± 0.78, and 6.9 ± 4.4 ng/mL in subjects with CGLD, AGLD, and controls (n = 19), respectively (ANOVA P < 0.0001). Specific insulin levels were 154 ± 172, 177 ± 137 and 43 ± 22 pmol/L, respectively (P < 0.0001). Insulin sensitivity was significantly decreased in both groups with LD (P < 0.0001), whereas HOMA ß-cell function was not significantly different when compared with controls. Leptin levels were significantly correlated with body mass index, insulin levels, and HOMA ß-cell function, and inversely correlated with insulin sensitivity in control subjects but not in subjects with generalized LD. In conclusion, decreased leptin levels were observed in subjects with generalized LD, with a trend towards lower levels in the acquired than in the congenital form (P = 0.06). The temporal relationship between the decrease in leptin levels and the development of lipoatrophy should be investigated in at-risk young relatives of subjects with the acquired forms to assess the usefulness of leptin levels as a marker of lipoatrophy.

This article has been cited by other articles:

				E. D. Javor, E. K. Cochran, C. Musso, J. R. Young, A. M. DePaoli, and P. Gorden Long-Term Efficacy of Leptin Replacement in Patients With Generalized Lipodystrophy Diabetes, July 1, 2005; 54(7): 1994 - 2002. [Abstract] [Full Text] [PDF]

				M. Fu, R. Kazlauskaite, M. d. F. Paiva Baracho, M. G. D. Nascimento Santos, J. Brandao-Neto, S. Villares, F. S. Celi, B. L. Wajchenberg, and A. R. Shuldiner Mutations in Gng3lg and AGPAT2 in Berardinelli-Seip Congenital Lipodystrophy and Brunzell Syndrome: Phenotype Variability Suggests Important Modifier Effects J. Clin. Endocrinol. Metab., June 1, 2004; 89(6): 2916 - 2922. [Abstract] [Full Text] [PDF]

				K. Ebihara, T. Kusakabe, H. Masuzaki, N. Kobayashi, T. Tanaka, H. Chusho, F. Miyanaga, T. Miyazawa, T. Hayashi, K. Hosoda, et al. Gene and Phenotype Analysis of Congenital Generalized Lipodystrophy in Japanese: A Novel Homozygous Nonsense Mutation in Seipin Gene J. Clin. Endocrinol. Metab., May 1, 2004; 89(5): 2360 - 2364. [Abstract] [Full Text] [PDF]

				K. B. Gomes, A. P. Fernandes, A. C. S. Ferreira, H. Pardini, A. Garg, J. Magre, and V. C. Pardini Mutations in the Seipin and AGPAT2 Genes Clustering in Consanguineous Families with Berardinelli-Seip Congenital Lipodystrophy from Two Separate Geographical Regions of Brazil J. Clin. Endocrinol. Metab., January 1, 2004; 89(1): 357 - 361. [Abstract] [Full Text] [PDF]

				S. S. Block, J. M. Smith, R. A. Ehrhardt, M. C. Diaz, R. P. Rhoads, M. E. Van Amburgh, and Y. R. Boisclair Nutritional and Developmental Regulation of Plasma Leptin in Dairy Cattle J Dairy Sci, October 1, 2003; 86(10): 3206 - 3214. [Abstract] [Full Text] [PDF]

				V. Simha, L. S. Szczepaniak, A. J. Wagner, A. M. DePaoli, and A. Garg Effect of Leptin Replacement on Intrahepatic and Intramyocellular Lipid Content in Patients With Generalized Lipodystrophy Diabetes Care, January 1, 2003; 26(1): 30 - 35. [Abstract] [Full Text] [PDF]

				F. LARCHER, M. DEL RIO, F. SERRANO, J. C. SEGOVIA, A. RAMIREZ, A. MEANA, A. PAGE, J. L. ABAD, M. A. GONZALEZ, J. BUEREN, et al. A cutaneous gene therapy approach to human leptin deficiencies: correction of the murine ob/ob phenotype using leptin-targeted keratinocyte grafts FASEB J, July 1, 2001; 15(9): 1529 - 1538. [Abstract] [Full Text] [PDF]

				K. Ebihara, Y. Ogawa, H. Masuzaki, M. Shintani, F. Miyanaga, M. Aizawa-Abe, T. Hayashi, K. Hosoda, G. Inoue, Y. Yoshimasa, et al. Transgenic Overexpression of Leptin Rescues Insulin Resistance and Diabetes in a Mouse Model of Lipoatrophic Diabetes Diabetes, June 1, 2001; 50(6): 1440 - 1448. [Abstract] [Full Text]

				D. Chen and A. Garg Monogenic disorders of obesity and body fat distribution J. Lipid Res., October 1, 1999; 40(10): 1735 - 1746. [Abstract] [Full Text]

				L. Poretsky, N. A. Cataldo, Z. Rosenwaks, and L. C. Giudice The Insulin-Related Ovarian Regulatory System in Health and Disease Endocr. Rev., August 1, 1999; 20(4): 535 - 582. [Abstract] [Full Text] [PDF]